首页> 美国卫生研究院文献>Technology in Cancer Research Treatment >Clinical Significance of Polo-Like Kinase 4 as a Marker for Advanced Tumor Stage and Dismal Prognosis in Patients With Surgical Gastric Cancer

【2h】

Clinical Significance of Polo-Like Kinase 4 as a Marker for Advanced Tumor Stage and Dismal Prognosis in Patients With Surgical Gastric Cancer

机译：Polo样激酶4作为外科胃癌患者晚期肿瘤阶段和抗病预后的标志物的临床意义

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

This study aimed to investigate the correlation of polo-like kinase 4 with clinicopathological features and survival profiles in patients with gastric cancer.

机译：本研究旨在探讨碱性激酶4与胃癌患者临床病理特征和存活谱的相关性的相关性。

著录项

期刊名称 Technology in Cancer Research Treatment
作者
Ting Cao; Shijie Yi; Xuefeng Yang; Qing Wu;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 8
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

机译：胃癌;Polo样激酶4;T阶段;TNM阶段;预后;

相似文献

外文文献
中文文献
专利

1. Clinical Significance of Polo-Like Kinase 4 as a Marker for Advanced Tumor Stage and Dismal Prognosis in Patients With Surgical Gastric Cancer [J] . Ting Cao, Shijie Yi, Xuefeng Yang, Technology in cancer research & treatment. . 2020,第6期

机译：Polo样激酶4作为外科胃癌患者晚期肿瘤阶段和抗病预后的标志物的临床意义
2. Significance of biological markers for predicting prognosis and selecting chemotherapy regimens of advanced gastric cancer patients between continuous infusion of 5-FU and a combination of 5-FU and cisplatin. [J] . Boku N, Ohtsu A, Yoshida S, Japanese journal of clinical oncology. . 2007,第4期

机译：生物标志物在连续输注5-FU与5-FU和顺铂联用之间预测晚期胃癌患者预后和选择化疗方案的意义。
3. Significance of Biological Markers for Predicting Prognosis and Selecting Chemotherapy Regimens of Advanced Gastric Cancer Patients between Continuous Infusion of 5-FU and a Combination of 5-FU and Cisplatin [J] . Narikazu Boku1 Atsushi Ohtsu2 Shigeaki Yoshida1 Kuniaki Shirao3 Yasuhiro Shimada3 Ichinosuke Hyodo4 Hiroshi Saito5 Yoshinori Miyata6 and Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group (GIOSG/JCOG) Japanese Journal of Clinical Oncology . 2007,第4期

机译：连续输注5-FU与5-FU和顺铂联用之间的生物学指标对晚期胃癌患者预后和化疗方案选择的意义
4. A Pilot Study of Expression and Clinical Significance of Stem Cell-Like Markers CD133 or CD24 in Different Subpopulations of Gastric Cancer Circulating Tumor Cells [C] . Shiyang Wu, Suyan Liu, Yan Dong, International Molecular Medicine Tri-Conference. . 2016

机译：干细胞样标志物CD133或CD24在胃癌循环肿瘤细胞不同亚群中的表达及临床意义的试验研究
5. Epigenetic Identification of Paired Box Gene 5 as a Functional Tumor Suppressor Associated with Poor Prognosis in Patients with Gastric Cancer. [D] . Li, Xiaoxing. 2010

机译：配对框基因5作为功能性肿瘤抑制因子的表观遗传学鉴定与胃癌患者预后不良相关。
6. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer [O] . Takahiro Toyokawa, Kazuya Muguruma, Mami Yoshii, 2020

机译：III期胃癌患者基于炎症的预后和/或营养指标的临床意义
7. Significance of biological markers for predicting prognosis and selecting chemotherapy regimens of advanced gastric cancer patients between continuous infusion of 5-FU and a combination of 5-FU and cisplatin [O] . 朴成和, ボクナリカズ 2008

机译：生物标志物对5-FU连续输注与5-FU联合顺铂联合化疗对晚期胃癌患者预后及化疗方案选择的意义
8. Tumor Marker CA 125: The Clinical Significance of the Serum Marker CA 125 in the Management of Patients with Ovarian Cancer [R] . van der Burg, M. E. L. 1989

机译：肿瘤标志物Ca 125：血清标志物Ca 125在卵巢癌患者管理中的临床意义

Clinical Significance of Polo-Like Kinase 4 as a Marker for Advanced Tumor Stage and Dismal Prognosis in Patients With Surgical Gastric Cancer

摘要

著录项

相似文献

相关主题

期刊订阅